TE Connectivity announces first quarter results for fiscal year 2025
EPS above guidance with record first quarter cash generation GALWAY, Ireland, Jan. 22, 2025 /PRNewswire/ -- TE Connectivity plc (NYSE:...
Day: January 22, 2025
Driving Innovation Through Diversity, Equity, and Inclusion: Insights From Black Book Research’s 2025 Study on Healthcare IT
Black Book Research Shares Key Insights and Recognizes Top 21 Vendors Advancing Diversity, Equity, and Inclusion TAMPA, FLORIDA / ACCESS...
CMS Doubles Down on Medicare Drug Price Controls, Threatening Patient Access and Innovation
ARLINGTON, VIRGINIA / ACCESS Newswire / January 22, 2025 / The Centers for Medicare & Medicaid Services (CMS) has announced...
Elevate Clinical Research Solutions Announces Launch of “Train and Build” Service Line and Webinar Series
Empowering Clinical Research Sites Through Tailored Training and Expertise MADISON, WISCONSIN / ACCESS Newswire / January 22, 2025 / Elevate...
Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update
Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million within five...
PRO-TECH Design & Manufacturing, Inc. Celebrates Forty-Five-Year Anniversary as Family-Owned Medical Device Contract Manufacturing Organization
Woman- and Family-Owned Medical Device Assembly and Packaging Company Marks 45 Years of Sustained GrowthSanta Fe Springs, California--(Newsfile Corp. -...
DRC Ventures Introduces the Ella Pure Peptide Cleanser: The Ultimate Purifying and Rejuvenating Skincare Experience
Franklin, Tennessee--(Newsfile Corp. - January 22, 2025) - DRC Ventures is proud to unveil the Ella Pure Peptide Cleanser, a...
Sidewalk Talk Celebrates 10-Year Anniversary with 2025 Listening Bus Tour
A Cross-Country Call to Connection and Compassion for Mental Health Awareness MonthSan Francisco, California--(Newsfile Corp. - January 22, 2025) -...
Masimo Announces Leadership Transition
Katie Szyman Appointed Chief Executive Officer and to Board of Directors Interim CEO Michelle Brennan Named Chairman of Masimo’s BoardIRVINE,...
Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved...
Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved...
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the BoardVancouver, British Columbia and Rehovot, Israel--(Newsfile...
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the BoardVancouver, British Columbia and Rehovot, Israel--(Newsfile...
Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - January 22, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - January 22, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
Live webcast on Wednesday, January 29th at 2:00 PM ETISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc....
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment...
Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
- Repurchasing all convertible note overhang, and - Funding pre-clinical and clinical trials - Management forfeiting $460,000 in accrued payroll...
NeuroSigma Announces Patent Application Protecting Use of Trigeminal Nerve Stimulation to Include Treatment of Dyslexia and Other Neurodevelopmental Disorders
LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve...
NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth...